Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial

The Lancet Oncology

Volumn 17, Issue 7, 2016, Pages 907-916

  Walter, Joan E ^a   Heuvelmans, Marjolein A ^a   de Jong, Pim A ^d   Vliegenthart, Rozemarijn ^a,b   van Ooijen, Peter M A ^a,b   Peters, Robin B ^b   ten Haaf, Kevin ^e   Yousaf Khan, Uraujh ^e   van der Aalst, Carlijn M ^e   de Bock, Geertruida H ^c   Mali, Willem ^d   Groen, Harry J M ^b   de Koning, Harry J ^e   Oudkerk, Matthijs ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Radiology ^*  (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NODULE; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMALL CELL LUNG CANCER; SMOKING; SQUAMOUS CELL LUNG CARCINOMA; TUMOR GROWTH; ADENOCARCINOMA; BELGIUM; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; FOLLOW UP; INCIDENCE; LUNG NEOPLASMS; MULTICENTER STUDY; MULTIPLE PULMONARY NODULES; NETHERLANDS; PATHOLOGY; PROBABILITY; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SMALL CELL LUNG CARCINOMA; SOFTWARE; X-RAY COMPUTED TOMOGRAPHY;

ADENOCARCINOMA; AGED; BELGIUM; CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIPLE PULMONARY NODULES; NEOPLASM STAGING; NETHERLANDS; PROBABILITY; PROGNOSIS; SMALL CELL LUNG CARCINOMA; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84973575851     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(16)30069-9     Document Type: Article

References (35)

1. 1 Jemal, A, Bray, F, Center, MM, Ferlay, J, Ward, E, Forman, D, Global cancer statistics. CA Cancer J Clin 61 (2011), 69–90.
2. 2 Midthun, DE, Jett, JR, Screening for lung cancer: the US studies. J Surg Oncol 108 (2013), 275–279.
3. 3 Field, JK, Van Klaveren, R, Pedersen, JH, et al. European randomized lung cancer screening trials: post NLST. J Surg Oncol 108 (2013), 280–286.
4. 4 Aberle, DR, Adams, AM, Berg, CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 (2011), 395–409.
5. 5 Jaklitsch, MT, Jacobson, FL, Austin, JHM, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 144 (2012), 33–38.
6. 6 Wood, DE, Eapen, GA, Ettinger, DS, et al. Lung cancer screening. J Natl Compr Canc Netw 10 (2012), 240–265.
7. 7 Bach, PB, Mirkin, JN, Oliver, TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307 (2012), 2418–2429.
8. 8 Detterbeck, FC, Mazzone, PJ, Naidich, DP, Bach, PB, Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143 (2013), e78S–e92S.
9. 9 Smith, RA, Manassaram-Baptiste, D, Brooks, D, et al. Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 65 (2015), 30–54.
10. 10 Moyer, VA, Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 160 (2014), 330–338.
11. 11 American Lung Association. American Lung Association provides guidance on lung cancer screening. http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/, 2012 (accessed Jan 24, 2015).
12. 12 de Koning, HJ, Meza, R, Plevritis, SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the US Preventive Services Task Force. Ann Intern Med 160 (2014), 311–320.
13. 13 Wilson, DO, Weissfeld, JL, Fuhrman, CR, et al. The Pittsburgh lung screening study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 178 (2008), 956–961.
14. 14 MacMahon, H, Austin, JHM, Gamsu, G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 237 (2005), 395–400.
15. 15 Swensen, SJ, Jett, JR, Sloan, JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 165 (2002), 508–513.
16. 16 Henschke, CI, Naidich, DP, Yankelevitz, DF, et al. Early Lung Cancer Action Project: initial findings on repeat screening. Cancer 92 (2001), 153–159.
17. 17 Henschke, CI, Yankelevitz, DF, Libby, DM, Pasmantier, MW, Smith, JP, Miettinen, OS, Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355 (2006), 1763–1771.
18. 18 Henschke, CI, Yankelevitz, DF, Yip, R, et al. Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology 263 (2012), 578–583.
19. 19 Carter, D, Vazquez, M, Flieder, DB, et al. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer 56 (2007), 193–199.
20. 20 Xu, DM, Yip, R, Smith, JP, Yankelevitz, DF, Henschke, CI, Retrospective review of lung cancers diagnosed in annual rounds of CT screening. Am J Roentgenol 203 (2014), 965–972.
21. 21 Xu, DM, Gietema, H, de Koning, H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 54 (2006), 177–184.
22. 22 Van Iersel, CA, De Koning, HJ, Draisma, G, et al. Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120 (2007), 868–874.
23. 23 van Klaveren, RJ, Oudkerk, M, Prokop, M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 361 (2009), 2221–2229.
24. 24 Gietema, HA, Wang, Y, Xu, D, et al. Pulmonary nodules detected at lung cancer screening: interobserver variability of semiautomated volume measurements. Radiology 241 (2006), 251–257.
25. 25 Heuvelmans, MA, Oudkerk, M, de Jong, PA, Mali, WP, Groen, HJM, Vliegenthart, R, The impact of radiologists' expertise on screen results decisions in a CT lung cancer screening trial. Eur Radiol 25 (2015), 792–799.
26. 26 Horeweg, N, Scholten, ET, de Jong, PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 15 (2014), 1342–1350.
27. 27 Horeweg, N, Van Der Aalst, CM, Thunnissen, E, et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 187 (2013), 848–854.
28. 28 Youden, WJ, Index for rating diagnostic tests. Cancer 3 (1950), 32–35.
29. 29 Callister, MEJ, Baldwin, DR, Akram, AR, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax 70:suppl 2 (2015), ii1–i54.
30. TM Version 1.0 assessment categories release date: April 28, 2014. http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/LungRADS/AssessmentCategories.pdf, 2014 (accessed Jan 22, 2015).
31. 31 Revel, M-P, Bissery, A, Bienvenu, M, Aycard, L, Lefort, C, Frija, G, Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable?. Radiology 231 (2004), 453–458.
32. 32 Horeweg, N, van Rosmalen, J, Heuvelmans, MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 15 (2014), 1332–1341.
33. 33 Field, JK, Oudkerk, M, Pedersen, JH, Duffy, SW, Prospects for population screening and diagnosis of lung cancer. Lancet 382 (2013), 732–741.
34. 34 Horeweg, N, Van Der Aalst, CM, Vliegenthart, R, et al. Volumetric computed tomography screening for lung cancer: Three rounds of the NELSON trial. Eur Respir J 42 (2013), 1659–1667.
35. 35 Heuvelmans, MA, Oudkerk, M, De Bock, GH, et al. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol 23 (2013), 1836–1845.